[Federal Register Volume 75, Number 218 (Friday, November 12, 2010)]
[Notices]
[Pages 69463-69464]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-28536]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 17, 2010 and published in the Federal Register 
on June 28, 2010, (75 FR 36681), Alltech Associates Inc., 2051 Waukegan 
Road, Deerfield, Illinois 60015, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed in 
schedules I and II:

------------------------------------------------------------------------
                       Drug                               Schedule
------------------------------------------------------------------------
Methcathinone (1237).............................  I
N-Ethylamphetamine (1475)........................  I
N,N-Dimethylamphetamine (1480)...................  I
4-Methylaminorex (cis isomer) (1590).............   I
Alpha-ethyltryptamine (7249).....................   I
Lysergic acid diethylamide (7315)................   I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine        I
 (7348).
Tetrahydrocannabinols (7370).....................   I
Mescaline (7381).................................   I
4-Bromo-2,5-dimethoxyamphetamine (7391)..........   I
4-Bromo-2,5-dimethoxyphenethylamine (7392).......   I
4-Methyl-2,5-dimethoxyamphetamine (7395).........   I
2,5-Dimethoxyamphetamine (7396)..................   I
2,5-Dimethoxy-4-ethylamphetamine (7399)..........   I
3,4-Methylenedioxyamphetamine (7400).............   I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)...   I
3,4-Methylenedioxy-N-ethylamphetamine (7404).....   I
3,4-Methylenedioxymethamphetamine (MDMA) (7405)..   I
4-Methoxyamphetamine (7411)......................   I
Alpha-methyltryptamine (7432)....................   I
Bufotenine (7433)................................   I
Diethyltryptamine (7434).........................   I
Dimethyltryptamine (7435)........................   I
Psilocybin (7437)................................   I
Psilocyn (7438)..................................   I
5-Methoxy-N,N-diisopropyltryptamine (7439).......   I
N-Ethyl-1-phenylcyclohexylamine (7455)...........   I
1-(1-Phenylcyclohexyl)pyrrolidine (7458).........   I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470).....   I
Dihydromorphine (9145)...........................   I
Normorphine (9313)...............................   I
Methamphetamine (1105)...........................   II
1-Phenylcyclohexylamine (7460)...................   II
Phencyclidine (7471).............................   II
Phenylacetone (8501).............................   II
1-Piperidinocyclohexanecarbo nitrile (8603)......   II
Cocaine (9041)...................................   II
Codeine (9050)...................................   II
Dihydrocodeine (9120)............................   II
Ecgonine (9180)..................................   II
Meperidine intermediate-B (9233).................   II
Noroxymorphone (9668)............................   II
------------------------------------------------------------------------

    The company plans to manufacture high purity drug standards used 
for analytical applications only in clinical, toxicological, and 
forensic laboratories.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Alltech Associates, Inc. to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Alltech Associates Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance 
with 21 CFR 1301.33, the above named company is granted

[[Page 69464]]

registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2010-28536 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-09-P